Staff who understand the benefits of digital manufacturing are as important as the technology itself, according to a Novartis expert Digitization is a hot topic for biopharma. Advocates say the ability to monitor and model manufacturing data in real-time as a major advantage in terms of product quality and consistency. Technology is driving the shift from analog. But having staff who understand the benefits is as important according to Francisca Gouveia, a Senior Process Expert, MS&T at Novartis, who says…
Monday, December 20, 2021 Daily Archives
Moderna to make millions of mRNA vaccines down under
Moderna will build an mRNA vaccine manufacturing plant in Victoria, Australia, which could produce up to 100 million doses each year, says firm. Moderna, which sprang to success on the back of its COVID-19 vaccine, laid out plans to construct a $500 million African messenger RNA (mRNA) facility in October. Now, the firm has announced an agreement with the Australian Government to build an mRNA vaccine plant in Victoria, including access to Moderna’s mRNA development technology. While the deal has…